Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-25
2006-07-25
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07081444
ABSTRACT:
A method of reducing damage to cells and tissue caused by an ischemic or hypoxic event is disclosed. The method includes administering to the cell or tissue, either in vivo or ex vivo, ψεRACK peptide. The peptide can be administered before, during or after the ischemic or hypoxic event.
REFERENCES:
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6329349 (2001-12-01), Liang et al.
patent: 6855693 (2005-02-01), Mochly-Rosen et al.
Chen et al. Oct. 1, 2001; Chemistry & Biology 8:1123-1129.
Dorn, G.W., et al.,PNAS 96(22):12798-12803, (1999).
Hahn, H.S., et al.,Circulation 102(18): Abstract No. 770, (2000).
Ron and Mochly-Rosen,Proc. Natl. Acad. Sci USA 92:492-496, (1995).
Carlson Karen Cochrane
Mohr Judy M.
Perkins Coie LLP
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
ΨεRACK peptide composition and method for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ΨεRACK peptide composition and method for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ΨεRACK peptide composition and method for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3572286